Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 23 (1-3) , 77-98
- https://doi.org/10.1016/s0169-409x(96)00427-9
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- In vitro systems for studying intestinal drug absorptionMedicinal Research Reviews, 1995
- Active transport of amino acids by gamma-glutamyl transpeptidase through Caco-2 cell monolayersBiochemical and Biophysical Research Communications, 1991
- Expression of dipeptidyl aminopeptidase IV during enterocytic differentiation of human colon cancer (Caco‐2) cellsInternational Journal of Cancer, 1991
- A Model of Human Small Intestinal Absorptive Cells. 1. Transport BarrierPharmaceutical Research, 1991
- Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.Journal of Histochemistry & Cytochemistry, 1990
- Epithelial Transport Of Drugs In Cell Culture. I: A Model For Studying The Passive Diffusion Of Drugs Over Intestinal Absorbtive (Caco-2) CellsJournal of Pharmaceutical Sciences, 1990
- Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal MucosaPharmaceutical Research, 1990
- Transport and permeability properties of human Caco-2 cells: An in vitro model of the intestinal epithelial cell barrierJournal of Controlled Release, 1990
- Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial PermeabilityGastroenterology, 1989
- Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colonThe Journal of Membrane Biology, 1987